DoJ drops complaint vs local drug distributor
M E T R O F I L E |
In a move upholding the Cheaper Medicine Law, the Department of Justice (DoJ) has dismissed a counterfeiting charge filed against a local drug distributor by three multinational companies. In a six-page resolution, penned by Assistant State Prosecutor Cesar Calubag, the DoJ found insufficient evidence of drug counterfeiting to indict Renante Dumasig. The complaint was filed by Astra Zeneca, Pfizer Phils. and Novartis. The DoJ panel said “while the complainants’ evidence tends to prove that the medicines seized from Dumasig on Nov. 18, 2010 were not registered with the Food and Drug Administration (FDA), their conclusion that the items were counterfeit lacks merit.” “A clearer scrutiny of the samples submitted by complainants would show the drugs were manufactured and registered in other country as appearing in their labels. This explains why the seized medicines were not registered with out FDA and the labels thereof were not in accordance with the Philippines Generic Labeling Requirements..... MORE
Source: The Daily Tribune
URL: http://www.tribuneonline.org/metro/20110926met7.html
1 comment
salamat at may hustisya pa rin naman pala. may pagasang makakuha ng murang gamot.
Post a Comment